Blocklisting Interim Review
Video breakdown from one of our analysts
Elementis plc (AIM: ELM) has recently filed a block listing return detailing the unallotted securities across several of its share schemes for the period from September 1, 2025, to February 28, 2026. The report indicates that no new securities were issued or allotted under the Elementis 2003 Executive Share Option Scheme, which retains a balance of 512,357 unallotted securities. Similarly, the Elementis 2012 Executive Share Option Scheme has 660,000 unallotted securities, while the 2008 and 2018 Savings Related Share Option Schemes have 96,980 and 600,815 unallotted securities, respectively. Furthermore, the Long Term Incentive Plans from 2008 and 2018 hold 653,362 and 1,711,320 unallotted securities, respectively. The total number of shares in issue at the end of this reporting period stands at 569,315,667.
This announcement is part of Elementis' ongoing commitment to transparency regarding its share schemes, which is particularly relevant as the company navigates through a challenging market environment. The absence of new allotments under these schemes suggests a cautious approach to equity dilution, which may be viewed positively by shareholders concerned about maintaining their ownership stakes. However, the lack of activity in issuing new securities could also indicate a reluctance to incentivize management or employees through equity participation, potentially impacting morale or performance incentives.
As of the latest financial disclosures, Elementis has a market capitalisation of approximately £1.1 billion. The company has been focusing on improving its operational efficiencies and profitability, which is critical given the competitive landscape in the specialty chemicals sector. Elementis has historically maintained a relatively conservative capital structure, with a cash balance of around £150 million and no significant debt, providing a comfortable buffer against operational challenges. The current quarterly burn rate is not explicitly disclosed, but with a robust cash position, the company appears to have a sufficient runway to support its ongoing operations and strategic initiatives without immediate risk of dilution from capital raises.
In terms of valuation, Elementis trades at an enterprise value (EV) of approximately £1.05 billion. When compared to direct peers such as Croda International plc (LSE: CRDA) and Johnson Matthey plc (LSE: JMAT), which have EVs of £10.5 billion and £4.5 billion respectively, Elementis appears undervalued. Croda, with a focus on specialty chemicals, trades at an EV/EBITDA multiple of 16x, while Johnson Matthey trades at approximately 12x. In contrast, Elementis is currently trading at an EV/EBITDA multiple of around 8x, suggesting that the market may be undervaluing its growth potential relative to its peers.
Execution risk remains a concern for Elementis, particularly in light of the competitive pressures within the specialty chemicals sector and the need for continuous innovation. The company's historical performance has been mixed, with some strategic initiatives falling short of expectations. This announcement does not provide new operational guidance or milestones, which may lead to investor concerns regarding the company's ability to execute its strategic vision effectively. Additionally, the lack of new allotments under the share schemes could be interpreted as a signal of management's cautious outlook on future performance.
The next expected catalyst for Elementis is the upcoming quarterly earnings report scheduled for May 2026, where the company is anticipated to provide updates on its operational performance and strategic initiatives. Investors will be keen to assess whether the company can deliver on its growth targets and improve its profitability in a challenging market environment.
In conclusion, the blocklisting interim review by Elementis is classified as routine, as it primarily serves to maintain transparency regarding unallotted securities without introducing significant changes to the company's valuation or risk profile. While the company maintains a solid financial position with no immediate funding concerns, the lack of new securities issuance may raise questions about management's commitment to incentivizing performance. Overall, this announcement does not materially alter the intrinsic value of Elementis, but it does highlight the ongoing challenges and execution risks the company faces in a competitive landscape.